Biomed Explorer Resposes for "Coverage with Evidence Development"

 Embedding Function into Health Care.

Abstract

… We focus here on three policy areas—Medicare coverage, quality reporting, and value-based payment programs—as vehicles for change that can enable, incentivize, or catalyze the integration of function as a standard element of clinical …

Ling, Lipp, Schreiber · Journal of the American Geriatrics Society · 2021-01-01

Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?

Introduction

… We found that concurrent with near-universal Medicare coverage at age 65, cancer detection increased by 72 per 100,000 population among women and 33 per 100,000 population among men; cancer mortality also decreased by nine per 100,000 …

Myerson, Tucker-Seeley, Goldman, Lakdawalla · Journal of policy analysis and management : [the journal of the Association for Public Policy Analysis and Management] · 2020-01-01

Medicare coverage

age 65

cancer detection

per 100,000 population

cancer mortality

Comparing Care for Dual-Eligibles Across Coverage Models: Empirical Evidence From Oregon.

Abstract

… more improvement in their care relative to those with nonaligned Medicare Advantage and Medicaid managed care plans. These results highlight the importance of developing policies that account for the heterogeneity of the dual population and …

Kim, Charlesworth, McConnell, Valentine, Grabowski · Medical care research and review : MCRR · 2019-10-01

more improvement

Medicare Advantage

Medicaid

manage care plan

Association Of State Policies With Medicaid Disenrollment Among Low-Income Medicare Beneficiaries.

Introduction

… We focused on Medicare beneficiaries who continuously received Low Income Subsidies for Medicare Part D prescription drug coverage (hereafter referred to as Part D subsidies), which have eligibility criteria closely aligned to …

Roberts, Hayley Welsh, Donohue, Sabik · Health affairs (Project Hope) · 2019-07-01

Medicare beneficiary

subsidy

Medicare Part D

prescription drug coverage

Part D

eligibility criterion

Summary of the 2018 Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) for transcatheter aortic valve replacement.

Abstract

… or maintain TAVR programs. In July 2018, the Centers for Medicare and Medicaid Services (CMS) convened a meeting of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) to review the evidence for setting minimum …

Rogers, Khan, Edelman, Waksman · Cardiovascular revascularization medicine : including molecular interventions · 2018-12-01

TAVR

July

Centers for Medicare and Medicaid Services

CMS

meeting

Evidence supporting FDA approval and CMS national coverage determinations for novel medical products, 2005 through 2016: A cross-sectional study.

2. Methods -> 2.1. Data Sources: Cms Ncds

… Medicare coverage determination process. NCDs are published memoranda that include the following information: the coverage decision (covered, covered with evidence development, or not covered), a concise background of the disease intended …

Roginiel, Dhruva, Ross · Medicine · 2018-10-01

Medicare

determination process

ncd

memoranda

coverage decision

Insurance coverage of heart transplantation in the United States: The dilemma, the debate and the definitive decision that ultimately determined the future of transplantation.

Evans · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2017-12-01

The Impact of Coverage Restrictions on Antipsychotic Utilization Among Low-Income Medicare Part D Enrollees.

Abstract

Prior research demonstrates substantial access problems associated with utilization management and formulary exclusions for antipsychotics in Medicaid, but the use and impact of coverage restrictions for these medications in Medicare Part D …

Roberto, Brandt, Onukwugha, Perfetto, Powers, Stuart · Administration and policy in mental health · 2017-11-01

Prior research

access problem

utilization management

exclusion

antipsychotic

Medicaid

restriction

Medicare Part D

Report of the Society for Vascular Surgery and the American Venous Forum on the July 20, 2016 meeting of the Medicare Evidence Development and Coverage Advisory Committee panel on lower extremity chronic venous disease.

Abstract

… and mechanisms that might be supported by the Centers for Medicare & Medicaid Services to improve the evidence base to optimize the care of patients with lower extremity CVD.

Gloviczki, Dalsing, Henke, Lal, O'Donnell, Shortell, Huang, Markovic, Wakefield · Journal of vascular surgery. Venous and lymphatic disorders · 2017-05-01

evidence base

Proposal for a national coverage determination for the treatment of varicose veins and venous disease due to disparate Centers for Medicare and Medicaid Services local coverage determination policies.

Abstract

… are not evidence based and provide unfair coverage of the same disease to the Medicare population, depending on where they live. Our proposal is for a national coverage determination policy for the treatment of varicose veins.

Welch, Kabnick, Vasquez, Monahan, Lurie, Jacobowitz · Journal of vascular surgery. Venous and lymphatic disorders · 2017-05-01